HEPATIC CELL CARCINOMA
Clinical trials for HEPATIC CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATIC CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEPATIC CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on liver cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called HRYZ-T102 for people with advanced liver cancer that has not responded to standard therapies. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer cells that produce a pro…
Matched conditions: HEPATIC CELL CARCINOMA
Phase: PHASE1 • Sponsor: Shanghai Ruiliyuan Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New scanner could spot liver danger before It's too late
Diagnosis Recruiting nowThis study is testing a new type of PET/MRI scan to see if it can give doctors a clearer picture of liver cirrhosis, liver cancer, and related high blood pressure. About 45 adults with cirrhosis will get this scan. The goal is to improve how doctors detect and monitor these serio…
Matched conditions: HEPATIC CELL CARCINOMA
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated May 04, 2026 16:22 UTC